Skip to main content

Sanna Bastiano's Form 4 filing

Vertex Pharmaceuticals Inc (VRTX) · filed May 18, 2022

Accession no.
0000899243-22-018605
Filed
May 18, 2022
Trade date
May 16, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions. Open-market sales total $11.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sanna BastianoCIK 0001829069Officer (EVP, Cell & Genetic Therapies)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 16, 2022Common StockSSaleDisposed−7$250.56F2,F3−$1,753.9241,787Direct
May 16, 2022Common StockSSaleDisposed−8$251.37F2,F4−$2,010.9641,779Direct
May 16, 2022Common StockSSaleDisposed−7$252.43F2,F5−$1,767.0141,772Direct
May 16, 2022Common StockSSaleDisposed−15$253.99F2,F6−$3,809.8541,757Direct
May 16, 2022Common StockSSaleDisposed−8$254.44F2,F7−$2,035.5241,749Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.

Referenced by the price of 5 transactions in Table I.

F3

Open market sales reported on this line occurred at a weighted average price of $250.56 (range $250.00 to $250.87).

Referenced by the price of 1 transaction in Table I.

F4

Open market sales reported on this line occurred at a weighted average price of $251.37 (range $251.00 to $251.88).

Referenced by the price of 1 transaction in Table I.

F5

Open market sales reported on this line occurred at a weighted average price of $252.43 (range $252.15 to $253.07).

Referenced by the price of 1 transaction in Table I.

F6

Open market sales reported on this line occurred at a weighted average price of $253.99 (range $253.33 to $254.32).

Referenced by the price of 1 transaction in Table I.

F7

Open market sales reported on this line occurred at a weighted average price of $254.44 (range $254.35 to $254.57).

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)